Drug intelligence / Profile preview

bupivacaine + saline

Development stage
Unknown
Lead developer
Tanta University
Modality
Small Molecules
Administration
External Oblique Intercostal Plane Block
01

Overview

The combination of bupivacaine and saline is a pharmacological preparation used primarily as a local anesthetic and as a control intervention in clinical research. Bupivacaine is a long-acting amide-type local anesthetic that functions by binding to the intracellular portion of voltage-gated sodium channels. This binding stabilizes the neuronal membrane and inhibits the ionic fluxes required for the initiation and conduction of nerve impulses, effectively blocking pain signals. In the context of clinical trials conducted by Tanta University, this specific formulation (typically 29 ml of 0.25% bupivacaine mixed with 1 ml of 0.9% saline) is administered via regional techniques such as the external oblique intercostal plane (EOIP) block to manage post-thoracotomy pain. Saline serves as an isotonic vehicle and diluent, often used to match the volume of an active adjuvant being tested in the experimental arm of a study.

Other names
29 ml bupivacaine 0.25% + 1 ml saline
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on bupivacaine + saline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bupivacaine + saline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call